5011 - 5020 of 8673 Results
Title
Year
- Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers2019OPENTitle: Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.038Best OA location URL: http://hdl.handle.net/10810/64481Citation Count: 21
-
OPENTitle: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic HypotensionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 3Start Page: 298End Page: 308Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12478Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12478Citation Count: 76
-
OPENTitle: MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSPJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 46Issue #:Start Page: 47End Page: 55Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.020Citation Count: 51
-
OPENTitle: Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington diseaseJournal Name: BMC Medical Informatics and Decision MakingPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12911-018-0714-7Best OA location URL: https://bmcmedinformdecismak.biomedcentral.com/track/pdf/10.1186/s12911-018-0714-7Citation Count: 39
-
OPENTitle: Myosin VI-Dependent Actin Cages Encapsulate Parkin-Positive Damaged MitochondriaJournal Name: Developmental CellPublisher: Elsevier BVVol: 44Issue #: 4Start Page: 484End Page: 499.e6Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.devcel.2018.01.007Best OA location URL: http://www.cell.com/article/S1534580718300078/pdfCitation Count: 101
-
OPENTitle: α-synuclein Imaging: A Critical Need for Parkinson's Disease ResearchJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 3Issue #: 4Start Page: 565End Page: 567Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130247Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130247?id=journal-of-parkinsons-disease%2Fjpd130247Citation Count: 80
-
OPENTitle: Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 88Issue #: 8Start Page: 653End Page: 662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2016-315023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7282477Citation Count: 100
-
OPENTitle: Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein FibrilsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 15Start Page: 6002End Page: 6017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b00571Citation Count: 107
- Absence of Sac2/INPP5F enhances the phenotype of a Parkinson’s disease mutation of synaptojanin 12020OPENTitle: Absence of Sac2/INPP5F enhances the phenotype of a Parkinson’s disease mutation of synaptojanin 1Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 22Start Page: 12428End Page: 12434Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2004335117Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7275725Citation Count: 39
-
RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 60